Active Ingredient History
Pancreatic enzymes, also known as pancreases or pancrelipase and pancreatin, are commercial mixtures of amylase, lipase, and protease. They are used to treat malabsorption syndrome due to certain pancreatic problems. These pancreatic problems may be due to cystic fibrosis, surgical removal of the pancreas, long term pancreatitis, or pancreatic cancer, among others. The preparation is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Injuries (Phase 3)
Bifidobacterium (Phase 4)
Celiac Disease (Phase 4)
Child Nutrition Disorders (Phase 2/Phase 3)
Colonic Polyps (Phase 4)
Cystic Fibrosis (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Drugs, Investigational (Phase 4)
Eructation (Phase 3)
Exocrine Pancreatic Insufficiency (Phase 4)
Gastrectomy (Phase 4)
Hypoglycemia (Phase 1)
Irritable Bowel Syndrome (Phase 4)
Kidney Failure, Chronic (Phase 3)
Malabsorption Syndromes (Phase 3)
Pancreatectomy (Phase 3)
Pancreatic Diseases (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 2)
Pancreatitis, Chronic (Phase 4)
Sepsis (Phase 2/Phase 3)
Short Bowel Syndrome (Phase 2)
Steatorrhea (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
